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Edited by Michael R. BubbAbstract The stabilisation of magnesium actin ﬁlaments by
phalloidin and jasplakinolide was studied using the method of dif-
ferential scanning calorimetry. The results showed that actin
could adapt three conformations in the presence of drugs. One
conformation was adapted in direct interaction with the drug,
while another conformation was identical to that observed in
the absence of drugs. A third conformation was induced through
allosteric inter-protomer interactions. The eﬀect of both drugs
propagated cooperatively along the actin ﬁlaments. The number
of the cooperative units determined by using a quantitative model
was larger for jasplakinolide (15 actin protomers) than for phal-
loidin (7 protomers).
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.1. Introduction
Actin is responsible for a number of cell functions in vivo
(for review, see [1,2]). To fulﬁl their biological functions, actin
ﬁlaments are able to assemble and disassemble rapidly under
the tight control of ﬁnely tuned regulatory mechanisms. In re-
cent years, many eﬀorts were made to understand the complex
interactions between actin and actin-binding ligands. The
models based on the application of actin-binding drugs proved
to be eﬀective to characterise intra-molecular mechanisms in
actin ﬁlaments [3–16].
In many cases, the eﬀect of the binding of a ligand to actin
ﬁlaments propagated along actin ﬁlaments through the inter-
action of neighbouring actin protomers [5,8,17–21]. The coop-
erative propagation of the eﬀect along actin ﬁlaments meant in
these studies that the binding of a ligand to actin ﬁlaments in-
duced conformational changes in the actin protomers distant
from the location of the bound ligand. It was proposed that
these cooperative interactions could play an important role
in the regulation of muscle contraction [22]. In many other
cases, the biological function of the cooperative behaviour of
actin ﬁlaments remained unknown.
We show here by using the method of DSC that saturation
of the binding sites by phalloidin or jasplakinolide stabilised
the structure of magnesium actin ﬁlaments. Under substoichio-
metric binding conditions, the eﬀect of the drugs propagated to
distant protomers from the binding site. A quantitative model
revealed that the number of cooperative units was 2-fold lar-*Corresponding author. Fax: +36 72 536261.
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doi:10.1016/j.febslet.2004.11.023ger for jasplakinolide (15 actin protomers) than for phalloidin
(7 protomers).2. Materials and methods
2.1. Actin preparation
Acetone-dried powder of rabbit skeletal muscle [23] and actin was
prepared as described previously [24]. The actin monomer bound cal-
cium was replaced with magnesium by adding 50 lM MgCl2 and 200
lM EGTA to Ca-G-actin and incubating the solution for 10 min at
room temperature. Mg-G-actin was polymerised by the addition of 2
mM MgCl2 and 100 mM KCl (ﬁnal concentrations).
2.2. Diﬀerential scanning calorimetry experiments
The thermal denaturation of Mg-F-actin was monitored in the ab-
sence or presence of phalloidin or jasplakinolide between 0 and 100
C with a SETARAMMicro DSC-II calorimeter. The actin concentra-
tion was 69 lM in the samples unless stated otherwise. The measure-
ments were carried out as described in [25] at pH 8.0 in 2 mM Tris/
HCl, 0.2 mM ATP, 0.005% NaN3, 0.5 mM 2-mercaptoethanol (buﬀer
A), 200 lM EGTA, 100 mM KCl and 2 mM MgCl2. The DSC curves
were deconvoluted using Microcal Origin 6.0 software. The errors
attributed to the determination of the integrals of the deconvoluted
Gaussian curves were less than 5%.3. Results and discussion
A number of ligands can induce conformational changes in
actin ﬁlaments, which propagate to distant protomers from the
binding site [5,8,17–19,21]. One of these ligands is phalloidin
[5,8]. We used here the phalloidin-actin complex as a reference
model. We tested whether the eﬀect of the binding of jasplak-
inolide was cooperative as well. Our aim was to provide a sim-
ple quantitative model to characterise the drug-induced
cooperative stabilisation of actin ﬁlaments.
3.1. The conformations of actin in the presence of phalloidin or
jasplakinolide
We used actin ﬁlaments with bound magnesium (Mg-F-ac-
tin) to study the eﬀects of phalloidin and jasplakinolide on ac-
tin ﬁlaments. DSC experiments were carried out at a series of
drug:actin protomer ratios ranging from 1:500 to 1:1. Jasplak-
inolide and phalloidin binds actin ﬁlaments tightly with aﬃni-
ties of 15 and 36 nM, respectively [6,26]. Under the conditions
applied here, more than 99% of the added toxin bound actin
protomers. Representative DSC transition curves are shown
in Fig. 1A and B. At substoichiometric drug concentrations,
the DSC curves usually showed three transitions with threeblished by Elsevier B.V. All rights reserved.
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Fig. 1. The thermal denaturation curves for the Mg-F-actin in the absence of toxins (0:1, black), and in the presence of phalloidin (A, C) and
jasplakinolide (B, D) at 1:1 (green), 1:5 (blue) and 1:100 (red) drug:actin protomer ratios as indicated in the ﬁgures. The actin concentration was 69
lM in panels A and B, and 23 lM in panels C and D. The experiments were carried out as described in Section 2.
B. Visegra´dy et al. / FEBS Letters 579 (2005) 6–10 7characteristic melting points. This complex nature of the DSC
curves suggested that the actin ﬁlaments were present in multi-
ple conformational states in these samples.
The processing of the DSC data was carried out by deter-
mining the Tm values for each melting components and then
the integrals (under-curve areas) attributed to the heat absorp-
tion curves at each Tm. The latter analyses involved deconvo-
lution and assumed that the individual melting curves were
Gaussian (Fig. 2). The calorimetric enthalpy changes (DH) of
endothermic transitions corresponding to the Tm values were














Fig. 2. Deconvolution analysis of the thermal denaturation curve
obtained with jasplakinolide stabilised actin ﬁlaments at 1:10 jasplak-
inolide:actin protomer molar ratio. The ﬁgure shows the measured
DSC curve (gray line), the three ﬁtted Gaussian curves (dashed lines)
and the curve obtained by summing the individual Gaussian curves
(solid black line). The analysis resolved Tm values of 68.1 C ðT amÞ, 76.9
C ðT bmÞ and 88.1 C ðT cmÞ with relative actin contributions of 16%,




m, respectively.absorption curves. The total molar enthalpy required for the
thermal denaturation of actin ﬁlaments was similar (650850
J/M) in the absence of drugs and in the presence of diﬀerent
drug concentrations. We used the enthalpies attributed to the
three Tm values as the measure of the amount of actin dena-
tured at the corresponding Tm value (Fig. 3A and B). T
a
m,
T bm and T
c
m are the Tm values at the lowest, intermediate and
the highest temperatures, respectively.
At each drug:actin protomer ratio T am was identical to the Tm
value measured in the absence of drugs and corresponded to the
actin conformation unaﬀected by drug binding. On the applied
temperature scale, another thermal transition peak ðT cmÞ ap-
peared at80 C and90 C for phalloidin and jasplakinolide,
respectively (Fig. 3), and were similar to that measured at a 1:1
drug:actin protomer ratio. The higher T cm value for jasplakino-
lide indicates that the stabilisation eﬀect of this drug is greater
onMg-F-actin than that of phalloidin. The stronger jasplakino-
lide eﬀect was also observed previously for Ca-F-actin [25]. The
integral attributed to the heat absorption curve corresponding
to T cm depended linearly on the drug concentrations within the
limits of experimental error (Fig. 3A and B).
These results suggest that there was a subpopulation of actin
protomers which directly bound drug and melted at a temper-
ature ðT cmÞ characteristic for the most stable actin conforma-
tion. There was a third component of the thermal
denaturation curves ðT bmÞ at intermediate drug concentrations
(Fig. 3A and B). The drug concentration dependence of the
integral attributed to the heat absorption curve corresponding
to T bm showed a maximum curve in the case of both phalloidin
and jasplakinolide (Fig. 3A and B). We interpret these data as
there was an actin population at intermediate drug:actin
protomer ratios which did not bind the drugs directly, but



















































Fig. 3. The lower panels show drug concentration dependence of the contribution of actin conformations corresponding to T am (empty squares), T
b
m
(empty circles) and T cm (empty triangles) to the total enthalpy required for denaturation. The results are shown for phalloidin (A) and jasplakinolide
(B). Linear lines show the drug dependence, which would be expected for the contribution of the actin characterised by T cm if only one actin monomer
(solid) or three actin monomers (dashed) are stabilised by direct drug binding. The upper panels show the drug concentration dependence of the
determined Tm values with corresponding ﬁlled symbols.
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site. The melting temperature ðT bmÞ characteristic for this third
actin population was greater than that measured in the absence
of toxins ðT amÞ, indicating that the allosteric interactions were
eﬀective to stabilise the conformation of actin protomers dis-
tant from the binding site. The comparison of T bm to T
c
m sug-
gests that full stabilisation eﬀect of the actin ﬁlaments
required direct drug binding to the actin protomers.
It was shown previously that actin ﬁlaments tend to form
bundles at high actin concentrations [27]. To test the eﬀect of
ﬁlaments bundling on the calorimetric data, control experi-
ments were carried out at 23 lM actin in the absence of drugs
and in the presence of substoichiometric (1:5) or saturating
(1:1) drug:actin protomer ratios. The results are presented in
Fig. 1C and D and showed that saturating drug concentrations
shifted the Tm value from 65.6 to 78.4 C and to 88.6 C in the
case of phalloidin and jasplakinolide, respectively. The deter-
mined molar enthalpy changes were within the range
(650850 J/M) measured at 69 lM actin. Although the calori-
metric data obtained at 23 lM actin were much noisier than at
69 lM actin, at substoichiometric drug:actin protomer ratios
the heat transition curves could be decomposed to three tran-
sition peaks. The Tm values attributed to these peaks were
64.2, 70.5 and 76.1 C in the presence of phalloidin, and
67.0, 77.1 and 86.7 C in the case of jasplakinolide. The relative
contribution of these peaks to the total enthalpy change were
17.5% (attributed to T am), 49.2% ðT bmÞ and 33.3% ðT cmÞ in the
case of phalloidin, and 13.5% ðT amÞ, 64.2% ðT bmÞ and 22.3%
ðT cmÞ in the case of jasplakinolide. These values measured at
23 lM actin concentration were in close agreement with those
obtained by us at 69 lM actin, indicating that the bundling of
actin ﬁlaments had no inﬂuence on the thermal denaturation
proﬁle of actin.
3.2. The stoichiometry of drug binding to actin ﬁlaments
An important aspect of understanding the mechanisms by
which drugs can aﬀect actin ﬁlaments is the stoichiometry of
their binding to actin ﬁlaments. For phalloidin, an early work
showed that all actin protomers bound phalloidin with a highaﬃnity [28], i.e., phalloidin bound to actin ﬁlaments in a 1:1
drug:actin protomer molar ratio. This observation was con-
ﬁrmed later by equilibrium measurements with a ﬂuorescent
derivative of phalloidin [4] and by structural analyses of actin
ﬁlaments decorated with undecagold cluster conjugated phal-
loidin [11]. Other laboratories suggested that the phalloi-
din:actin protomer ratio was 1:2 from the results of solution
experiments [29] and the determination of the phalloidin bind-
ing site in the reﬁned actin ﬁlament structure [30]. Our data set
is more consistent with the 1:1 phalloidin:actin protomer (and
jasplakinolide:actin protomer) binding ratio as the further
addition of these drugs above the 1:2 ratio induced further
modiﬁcation in the thermal denaturation curves, and thus in
the conformational equilibrium established by actin.
It is established that one phalloidin molecule interacts with
more than one, most likely three, actin protomers in an actin ﬁl-
ament [15,30]. Jasplakinolide binds actin ﬁlaments competi-
tively with phalloidin [6], presumably due to their common
binding site. In our experiments, the drug concentration depen-
dence of the ratio of the most stabilised actin population (corre-
sponding to T cm) increased linearly with a slope of 1 (solid line
in Fig. 3A and B). This most stable actin population represented
an actin conformation, which was stabilised by a direct interac-
tion with phalloidin or jasplakinolide. If the binding of one drug
molecule would have stabilised three actin monomers [15,30] to
an extent observed under saturating conditions (in a 1:1 dru-
g:actin protomer ratio), the slope of such a plot would be 3
(dashed lines in Fig. 3A and B). The experimental results devi-
ated from the dashed lines (Fig. 3A and B). Therefore, the DSC
data suggest that only one out of the three drug-bound actin
protomers was stabilised to the maximum extent by the direct
binding of one phalloidin or jasplakinolide.
3.3. A simple model to describe cooperativity
Our data showed that actin could exist in three conforma-
tions in the presence of phalloidin or jasplakinolide. To quan-
titatively describe the cooperative interactions along the actin
ﬁlaments, we assumed that these drugs bind randomly to actin
protomers. We attempted to determine the number (2k) of
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Fig. 4. The ratio (N/N0) of the concentration of actin monomers which
were not aﬀected by the binding of phalloidin (ﬁlled circles) or
jasplakinolide (empty circles) as a function of the probability (the ratio
of the drug concentration to the actin concentration) that an actin
monomer binds a drug molecule. The N/N0 values were determined
from the experimental data, while the probabilities were given by the
applied drug:actin protomer ratios. The ﬁtted lines generated by using
Eq. (2). are shown. The ﬁts gave k values of 3.0 ± 0.5 protomer and
6.9 ± 1.1 protomer for phalloidin and jasplakinolide, respectively.
B. Visegra´dy et al. / FEBS Letters 579 (2005) 6–10 9cooperative units (number of protomers), over which the eﬀect
of the binding of an individual drug molecule can propagate.
The probability that an actin protomer binds the drug (p)
equals to the drug:actin protomer ratio, while the probability
that a protomer does not bind the drug is 1  p. There are
two criteria to have no eﬀect from drug binding on a randomly
chosen protomer: (i) it should not bind the drug, and (ii) no
drug should be bound to the neighbouring 2k protomers. If
N0 is the total number of monomers in a ﬁlament, there are
statistically (1  p) N0 protomers, which do not bind the drug.
The probability that any protomer has 2k neighbouring pro-
tomers with no bound drug is (1  p)2k. Let N be the number
of actin protomers in a ﬁlament, which are not aﬀected by drug
binding. The probability that a protomer is not aﬀected by the
drug binding (N/N0) is given by
N=N 0 ¼ ð1 pÞ2kþ1 ð2Þ
The N/N0 ratio was experimentally determined from the rel-
ative contribution of the actin conformation which was char-
acterised by T am in Fig. 3, while the actual value of p was
given by the applied drug:actin protomer ratio. When Eq.
(2). was ﬁtted to the p vs. N/N0 plots (Fig. 4), the value of k
was determined to be 3.0 ± 0.5 and 6.9 ± 1.1 for phalloidin
and jasplakinolide, respectively. Accordingly, the binding of
one phalloidin molecule could change the conformation of
2k + 1 = 7 actin protomers, while one jasplakinolide could
modify 15 actin protomers. These values showed that the range
of allosteric interaction along the actin ﬁlament was longer for
jasplakinolide than that for phalloidin. This model is not sen-
sitive to the directionality of the drug eﬀect. We cannot distin-
guish between cases where the binding of a drug molecule was
propagated towards only one end of the ﬁlaments to an extent
of 2k protomers and the case where the drug stabilised 2k pro-
tomers distributed uniformly in both directions around the
drug-bound protomer.
3.4. Conclusions
We showed here that stabilisation eﬀect of phalloidin and
jasplakinolide on magnesium actin ﬁlaments was cooperative.To describe the experimental data, we established a simple
quantitative model, which revealed that the number of cooper-
ative units was larger for jasplakinolide (15 actin protomers)
than that for phalloidin (7 protomers).
The biological importance of the ability of actin protomers
to transfer information cooperatively along actin ﬁlaments is
not understood. In vivo actin ﬁlaments function under the
tight control of complex regulatory mechanisms. Such mecha-
nisms often involve the binding of the actin-binding proteins
and the changes in the ﬁlament conformation and/or dynamics
induced by the binding of these partner molecules. It might be
possible that the cooperativity along actin ﬁlaments can serve
in vivo as an information channel allowing the diﬀerent eﬀec-
tors to express their full eﬀect even under substoichiometric
binding conditions. Although this hypothesis needs further
experiments to test, such information channels would certainly
serve a better economy and less energy consumption of living
cells.
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